Showing results (31-40 of 179) with videos related to

Sort By:
Pageof 18
The Lancet Regional Health. Europe|September 12, 2024
SGLT2 inhibitors for patients with type 2 diabetes mellitus after myocardial infarction: a nationwide observation registry study from SWEDEHEARTHans Christian Rosén, Moman A Mohammad, Tomas Jernberg, et al.
Journal of the American Heart Association|January 14, 2026
Plasma Biomarkers Associated With Heart Failure Hospitalization Among Patients With Atrial Fibrillation and Subtypes of Heart FailureTymon Pol, Johan Lindbäck, Jonas Oldgren, et al.
International Journal of Cardiology|June 27, 2006
Artificial neural network algorithms for early diagnosis of acute myocardial infarction and prediction of infarct size in chest pain patientsKai M Eggers, Johan Ellenius, Mikael Dellborg, et al.
Journal of the American College of Cardiology|July 31, 2010
Eptifibatide is noninferior to abciximab in primary percutaneous coronary intervention: results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry)Axel Akerblom, Stefan K James, Michail Koutouzis, et al.
Clinical Biochemistry|October 14, 2009
Myeloperoxidase is not useful for the early assessment of patients with chest painKai M Eggers, Mikael Dellborg, Nina Johnston, et al.
European Stroke Journal|February 27, 2026
Early versus delayed DOAC after ischaemic stroke in atrial fibrillation: 1-year outcomes in the TIMING study and in concurrent practiceOskar Fasth, Jonas Oldgren, Tatevik Ghukasyan Lakic, et al.
JRSM Cardiovascular Disease|April 26, 2019
Low Walking Impairment Questionnaire score after a recent myocardial infarction identifies patients with polyvascular diseaseBirgitta Jönelid, Björn Kragsterman, Lars Berglund, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|August 4, 2021
Screening of biomarkers for prediction of multisite artery disease in patients with recent myocardial infarctionBirgitta Jönelid, Christina Christersson, Pär Hedberg, et al.
Pageof 18